Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
Status:
Completed
Trial end date:
2018-09-18
Target enrollment:
Participant gender:
Summary
Study Hypothesis: When mycophenolate mofetil is added to tacrolimus in the treatment of
membranous glomerulonephritis it is likely to improve the initial response to treatment and
reduce the risk of relapse on stopping therapy.